DiaMedica Therapeutics (DMAC) Change in Acquisitions & Divestments (2019 - 2026)

DiaMedica Therapeutics has reported Change in Acquisitions & Divestments for 8 years, with the latest figure at $16.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 24.37% year-over-year to $16.8 million; the trailing twelve-month figure through Mar 2026 stood at $60.4 million (up 3.28% YoY), and the FY2025 full-year result was $57.1 million, down 3.18% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $16.8 million, up from $16.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $18.5 million in Q2 2025, with the low at $9.1 million in Q3 2025.
• Historically, Change in Acquisitions & Divestments has averaged $14.2 million across 5 years, with a median of $14.5 million in 2022.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments jumped 45.45% — and 2025, when it tumbled 43.1%.
• DiaMedica Therapeutics' Change in Acquisitions & Divestments stood at $14.5 million in 2022, then fell by 24.37% to $11.0 million in 2023, then jumped by 45.45% to $16.0 million in 2024, then advanced by 0.34% to $16.1 million in 2025, then advanced by 4.58% to $16.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $16.8 million (Q1 2026), $16.1 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.